Although further studies increasing the number of CSF derived ctDNA are required, we found serum as the most promising alternative rather than plasma for BRAF V600E by dPCR detection in liquid biopsy from CNS pediatric cancers. The gene discussed is BRAF; the disease is childhood malignant neoplasm.